Andrew Evens, DO, and Joanna Rhodes, MD, discuss evolving CLL treatment paradigms, CAR T-cell therapy versus bispecific antibodies, and expanding community access to specialized lymphoma care.
Andrew Evens, DO, MBA, MSc, SVP
Advertisement
Articles by Andrew Evens, DO, MBA, MSc, SVP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Cancer Surgery Waiting Times Rising: What Oncology Nurses Need to Know
2
Nurses: The Lifeline for Dietitian Referrals in Cancer Care
3
Active Surveillance Rates Rise for Prostate Cancer in Veterans Health System
4
What Nurses Need to Know About FDA-Approved Iberdomide in Multiple Myeloma
5